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Abstract
Background—The cardiac sodium channel SCN5A regulates atrioventricular and ventricular
conduction. Genetic variants in this gene are associated with PR and QRS intervals. We sought to
further characterize the contribution of rare and common coding variation in SCN5A to cardiac
conduction.
Methods and Results—In the Cohorts for Heart and Aging Research in Genomic
Epidemiology Targeted Sequencing Study (CHARGE), we performed targeted exonic sequencing
of SCN5A (n=3699, European-ancestry individuals) and identified 4 common (minor allele
frequency >1%) and 157 rare variants. Common and rare SCN5A coding variants were examined
for association with PR and QRS intervals through meta-analysis of European ancestry
participants from CHARGE, NHLBI’s Exome Sequencing Project (ESP, n=607) and the UK10K
(n=1275) and by examining ESP African-ancestry participants (N=972). Rare coding SCN5A
variants in aggregate were associated with PR interval in European and African-ancestry
participants (P=1.3×10−3). Three common variants were associated with PR and/or QRS interval
duration among European-ancestry participants and one among African-ancestry participants.
These included two well-known missense variants; rs1805124 (H558R) was associated with PR
and QRS shortening in European-ancestry participants (P=6.25×10−4 and P=5.2×10−3
respectively) and rs7626962 (S1102Y) was associated with PR shortening in those of African
ancestry (P=2.82×10−3). Among European-ancestry participants, two novel synonymous variants,
rs1805126 and rs6599230, were associated with cardiac conduction. Our top signal, rs1805126
was associated with PR and QRS lengthening (P=3.35×10−7 and P=2.69×10−4 respectively), and
rs6599230 was associated with PR shortening (P=2.67×10−5).
Conclusions—By sequencing SCN5A, we identified novel common and rare coding variants
associated with cardiac conduction.
Keywords
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The PR and QRS intervals are electrocardiographic measures of cardiac atrioventricular
conduction. Community-based studies have identified associations between PR and QRS
measurements and adverse cardiovascular outcomes. PR prolongation has been associated
with risk of atrial fibrillation (AF), pacemaker implantation, heart failure and all-cause
mortality.1–3 QRS prolongation has been associated with heart failure and cardiovascular
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mortality in clinical-trial and community-based cohorts.4–8 Genome-wide association
studies (GWAS) and candidate gene studies have identified common genetic variants in the
cardiac sodium channel SCN5A gene to be associated with PR and QRS intervals among
those of European and African ancestry.9–14 Missense mutations in this gene have been
associated with supraventricular and ventricular arrhythmias.15
The functional contributions of lower frequency and rare variants to PR and QRS intervals
in the general population remain largely unknown. In the present study we sought to: (1)
sequence the SCN5A gene to catalog coding variants in this gene; (2) examine the
associations of rare SCN5A coding variants with PR and QRS intervals; and (3) identify
novel associations of common and low frequency coding variants, perhaps poorly tagged by
GWAS, with cardiac conduction. To address these aims, we combined exonic sequencing of
the SCN5A gene across multiple consortia: the Cohorts for Heart and Aging Research in
Genomic Epidemiology Targeted Sequencing Study (CHARGE), the National, Heart, Lung,
and Blood Institute’s Exome Sequencing Project (ESP), and the United Kingdom-based
UK10K.
Methods
Study samples – CHARGE
CHARGE conducted targeted sequencing on a sample of participants selected for their
extremes of PR and QRS phenotypes from the Atherosclerosis Risk in Communities (ARIC)
Study, the Cardiovascular Health Study (CHS), and the Framingham Heart Study (FHS). In
all three cohorts the PR and QRS phenotypes were ascertained from standardized
applications of 12-lead electrocardiograms (ECG). ECG analysis and quantification of the
PR and QRS phenotypes for the three cohorts have been presented elsewhere.12,13,16
The comprehensive methods for sequencing are presented by Lin et al. in the accompanying
manuscript. In brief, 77 loci identified in prior GWAS were selected for sequencing at the
Baylor College of Medicine Human Genome Sequencing Center. In total 52,736 unique
variants were identified using the SOLiD™ platform-based multiplexed sequencing protocol
developed specifically for the CHARGE. SAMtools17 was used for variant detection and
calling. Individual variant calls that were >100 base pairs from the capture region, of low
quality (Phred-scaled base quality <30), with fewer than 2 reads of the alternate allele or
fewer than 10 reads overall were set to missing. Variant sites within a cohort failing any of
the following criteria were removed: (1) allelic imbalance ratio that was greater than 80% or
less that 20%; (2) missingness rate greater than 20%; (3) deviation from Hardy-Weinberg
Equilibrium (HWE) with a p value of < 1×10−5; or (4) reporting >1 alternative alleles. Too
many variants within a short genomic interval can indicate regional sequencing errors or
uncalled structural variants. Dense clusters of SNPs, defined as 3 or more SNPs in a 10bp
window, were therefore removed. The present analysis is focused solely on the results of
targeted exome sequencing of SCN5A and its association with the PR and QRS intervals.
For PR interval participant selection, individuals at the upper tail of the trait distribution
were selected using a model employing the ECG phenotype as the independent variable and
age, sex, study center, height, and body mass index as dependent variables. For QRS
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duration selection, individuals were chosen at the upper tail of the distribution of the
phenotype. For both phenotypes, 100 participants from ARIC, 50 from CHS, and 50 from
FHS, with equal numbers of men and women, were selected for sequencing following
exclusions. CHARGE participants were excluded from the analysis for the following: non-
white race; lacking PR or QRS measurement; prevalent atrial fibrillation; history of
myocardial infarction or heart failure; pacemaker implantation; or use of Class I or III
antiarrhythmic medications. Individuals with QRS duration>120 ms were also excluded
from the QRS analysis.
The examination of common variation in genotypes imputed to 1000 Genomes included all
participants of European descent in ARIC, CHS and FHS with available imputed genotypes.
Details of the genotyping platform, quality control imputation, and reference panel are
provided in the Supplemental methods.
Study Samples – ESP
ESP is designed to examine genomic associations with heart, lung, and blood diseases.
Participants in ESP were selected from cohort studies by having extremes of quantitative
phenotypes (low-density lipoprotein cholesterol, blood pressure, body mass index) or
disease endpoints (e.g., ischemic stroke, early onset myocardial infarction).18 Library
construction, exome capture, sequencing, mapping, calling and filtering have been described
elsewhere.18,19 Briefly, deep (60–80× target depth) whole exome sequencing was performed
at two genome centers using Illumina GAII or HiSeq2000 sequencers. SNVs were called
using the UMAKE pipeline at University of Michigan, utilizing glfMultiples4 software that
implements a maximum-likelihood model and allowed all samples to be analyzed
simultaneously. Reads were mapped using human reference (hg19) with Burrows-Wheeler
Aligner20 and summarized in BAM files for joint calling input. All low quality reads (Phred-
scaled mapping quality < 20) and pair-end reads likely to be PCR duplicates were removed.
Sites deemed to be false positive were excluded from further analyses. Variant calls with a
read depth <10× were set to missing. Variant sites were removed if the mean sample read
depth across all samples was >500×, the variant deviated from race-specific HWE
(p<1×10−7). A support vector machine (SVM) classifier was used to separate likely true
positive and false-positive variant sites as described elsewhere.21 SVM filtering started by
collecting a series of features related to quality of each SNV, including overall depth,
fraction of samples with coverage, allelic imbalance, correlation of alternative alleles with
strand and read position (strand and cycle bias), and inbreeding coefficient for each variant.
SNVs that deviated significantly from expected values in three or more categories were
flagged as likely false positives when training the SVM filter. Multidimensional scaling was
performed in order to validated European and African ancestry.
ESP participants were excluded for lacking PR or QRS measurement, pacemaker or
defibrillator implantation, or prevalent AF. European ancestry ESP samples with available
ECG measurements come from ARIC, CHS, FHS, Multi-Ethnic Study of Atherosclerosis
(MESA), and the Women’s Health Initiative (WHI). To avoid sample overlap with the
CHARGE sample, ARIC, CHS and FHS participants of European ancestry were excluded
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from the ESP analysis. In the present analysis, the ESP African-ancestry sample consisted of
participants from ARIC, CHS, the Jackson Heart Study, MESA, and WHI.
Study Samples – UK10K
UK10K (http://www.uk10k.org/) is a large-scale sequencing project, based on collaboration
between investigators at the Wellcome Trust Sanger Institute and clinical experts in genetic
diseases. The aims were to associate genetic variation with phenotypic traits and identify
rare variants contributing to disease in the TwinsUK Registry (http://www.twinsuk.ac.uk/), a
cohort study investigating the genetic epidemiology of diverse traits and diseases in twins
that has been described in detail.12 Low coverage whole-genome sequencing was performed
at the Wellcome Trust Sanger Institute and the Beijing Genomics Institute using the Illumina
HiSeq platform according to manufacturer’s protocol. Variant calls were made using
SAMtools/bcftools17 by pooling the alignments from individual low coverage BAM files.
The Genome Analysis Toolkit22 was used to filter sites (Variant Quality Score
Recalibration, VQSR)23 and to model and calibrate the variants. The VQSLOD score for
SNPs was set to −0.6804, setting the maximum truth sensitivity tranche to 99.5%.
Samples were excluded if there was a high overall discordance to SNP array data (>3%), if
the heterozygosity rate was larger than 3SD from population mean or if the mean read depth
was below 4×. To ensure only samples of European ancestry were included, the dataset was
pruned to the HapMap3 populations, followed by principal components analysis using
EIGENSTRAT,24 after which samples were removed that did not cluster to European
ancestry. Hereafter were excluded related samples (IBD > 0.125, third degree relatedness)
and checked zygosity in the sequence data against zygosity in GWA data using identity by
state, removing co-twin samples (dizygotic and monozygotic). This procedure led to a final
dataset of 1754 complete sequences, with an overall read depth of 6.95×.
PR and QRS intervals were obtained in TwinsUK from standardized methods with
automated measurement by the Cardiofax ECG-9020K (Nihon Kohden UK Ltd., Middlesex,
UK). UK10K participants were excluded for non-European ancestry, missing the PR or QRS
phenotypes, prevalent atrial fibrillation, or a history of pacemaker implantation.
As we used exome sequencing from 3 different studies in our analysis, we compared the
quality control metrics and calling approaches across the studies. In particular, rare variants
are challenging to call consistently and may be spurious; we therefore characterized the
quality of our variants in Supplemental Table 1, which includes number of variants called,
TiTv ratio and average depth of coverage across the 3 studies.
Statistical analysis
Briefly, we categorized variation into two classes: rare (< 1% minor allele frequency
[MAF]) or common. Common variants were examined individually using linear regression
in CHS, ARIC, ESP and UK10K, and linear mixed effect models in FHS to account for
familial structure. Analyses for both PR and QRS intervals were adjusted for age, sex,
height, body mass index and cohort. Analyses in ESP were additionally adjusted for
principal components, phenotype sampling group and sequence center. In the CHARGE,
analyses weighted by the sampling probabilities were conducted to obtain unbiased
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population effect estimates. We combined results using fixed-effects inverse variance
weighted meta-analysis of study-specific association estimates. We initially combined
results from the 3 CHARGE cohorts. We then combined results from the CHARGE, ESP,
and UK10K studies. Analysis of 1000 Genomes imputed data from ARIC, CHS, and FHS
used the same adjustments and were combined with a fixed-effects inverse variance
weighted meta-analysis of the study-specific association estimates.
For each phenotype, we adjusted for multiple testing using a Bonferroni correction. Among
those of European ancestry, four common coding single nucleotide polymorphisms (SNPs)
were examined, and a meta-analytic P<0.0125 (0.05/4 variants) was deemed significant for
each phenotype. For individuals of African ancestry, 10 SNPs were examined and a meta-
analytic P<0.005 (0.05/10 variants) was deemed significant for each phenotype. Pairwise R2
values were reported from the SNAP web interface using the 1000 Genomes project Pilot 1
data.25
Rare variation in the coding regions was jointly analyzed using the Sequence Kernel
Association Test (SKAT), which was adapted for a meta-analysis framework26 as described
in the accompanying methods paper. Unlike burden tests, the SKAT test does not assume a
consistent direction of effect for all variants. There have been several reports of mutations in
ion channel genes, some of which increase and some that decrease channel function,27–29
hence we select the SKAT omnidirectional test over simpler variant collapsing rare variant
tests. Disease causing mutations have been cataloged along the entire length of the sodium
channel,30 implying multiple or broad functional domains. We therefore determined a priori
to include all coding rare variants along the length of SCN5A in a single, combined rare
variant test. All SKAT tests were adjusted for age, sex, height, body mass index and study
specific population variables. ESP analyses were additionally adjusted for principal
components, phenotype sampling group and sequence center. Consortium results were
combined with a Fisher’s p-value meta-analysis. We deemed the threshold for statistical
significance as 0.05 for each phenotype.
All study participants provided informed consent. Institutional review board oversight and
approval was performed by each of the participating studies.
Results
In total, the CHARGE population consisted of 3699 individuals of European ancestry from
three community-based cohort studies (ARIC, n=1645; CHS, n=1021; FHS, n=1033). There
were 1579 participants in the ESP samples, of whom 972 (61.6%) were of African ancestry.
The UK10K study examined 1275 individuals of European ancestry. Mean PR interval in
each study ranged from 152 ms to 171 ms, and mean QRS interval from 88 ms to 95 ms
(Table 1). Cohort characteristics are described in Table 1.
SNP Catalog
Targeted exonic sequencing of SCN5A in 3699 CHARGE European-descent participants
identified 157 rare variants (3 nonsense variants, 4 intronic splice site variants, 91
nonsynonymous SNPs, and 59 synonymous SNPs), as shown in Figure 1. Most of these rare
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variants were novel (N=134, 85%) compared to 1000 Genomes Pilot 1 data. Four common
(MAF>1%) coding variants (1 nonsynonymous, 3 synonymous variants) were identified.
While none of these common variants are novel, 2 were not present in HapMap2 and hence
not investigated by prior large-scale GWAS efforts. Similarly, targeted sequencing among
ESP and UK10K European-ancestry individuals identified only these 4 common variants.
Among 972 African ancestry participants in ESP, we identified 10 common variants (4
nonsynonymous, 6 synonymous) and 71 rare variants (40 nonsynonymous, 31 synonymous).
Rare Variant Analysis
We jointly analyzed the rare coding variation in SCN5A using SKAT for association with
cardiac conduction. We found rare variants in aggregate were associated with PR interval in
both European (P=0.01) and African-ancestry (P=0.01) participants separately and
combined (meta-analytic P=8.9×10−3), but not with the QRS interval (Table 2 presents the
gene-based test associations for the ECG phenotypes across the 3 studies). Among the
individual rare variants, there was no clustering of more extreme effects within any specific
functional regions of the gene including the pore-forming domains (Figure 2). The effect
size for rare variants ranged from PR shortening of 60ms to PR lengthening of 120ms. We
identified 3 singleton nonsense variants among those of European ancestry in the CHARGE.
Individuals with nonsense variants had PR intervals both shorter and longer than the mean
PR interval (Figure 2). No nonsense variants were identified among the 972 African
ancestry participants.
Common Variant Analysis
Across the three European ancestry studies (n=5581), three of the four common coding
variants were associated with the PR interval (Table 3) and two with QRS duration (Table
4). The well-characterized nonsynonymous SNP (rs1805124, MAF 18.4%, H558R in the I–
II loop of the SCN5A channel) was associated with shorter PR (beta= −2.44 ms;
P=6.25×10−4) and QRS (beta= −0.77ms; P=5.20×10−3) intervals in meta-analysis across the
CHARGE, ESP, and UK10K studies (Table 3 and 4). In addition to H558R, we identified
two novel associations between common synonymous SNPs and cardiac conduction. The
strongest association was with rs1805126 (D1818D, MAF 33.6%), which was associated
with both PR (beta=2.51 ms, P=3.35×10−7) and QRS (beta=0.67 ms; P=2.69×10−4) interval
prolongation in meta-analysis. The second novel synonymous SNP (rs6599230, A29A,
MAF 21.9%) was associated with PR shortening (beta= −2.40 ms, P=2.67×10−5). No
significant heterogeneity of effect was detected across the cohorts for the common variants,
P>0.05 for all comparisons (Tables 3 and 4). While the three variants associated with
cardiac conduction in our study were not in LD with each other (R2<0.06), two of the SNPs
were in at least modest LD with previously identified PR or QRS SNPs. D1818D
(rs1805126) was in high LD (0.78) with intronic SNP rs10865879, the top signal associated
with PR and QRS intervals from prior GWAS studies.12,13 H558R, rs1805124, was not in
LD with the top index SNPs associated with PR or QRS in prior reports, but in modest LD
(R2=0.21) with a secondary SCN5A-QRS signal (rs11710077).12 By contrast, the novel
synonymous SNP rs6599230 (A29A) was not in LD (r2<0.05) with any previously
identified independent SCN5A index signal from GWAS studies of cardiac atrioventricular
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or ventricular conduction, and may represent a new independent association signal (Table
5).
To increase the sample size examined for common variants, we performed 1000 genomes
imputation on GWAS data from 9374, 2833, and 7837 European-descent individuals from
ARIC, CHS, and FHS, respectively (Supplemental Table 2). Meta-analysis across the
combined 20,044 individuals in ARIC, CHS, and FHS showed that all three of these coding
SNPs were strongly associated with PR and QRS intervals (Supplemental Table 3).
Among African Americans, we examined the association of 10 common coding variants
(including the 4 identified among those of European ancestry), with PR and QRS intervals.
The three SNPs associated with PR and QRS among European-descent individuals were not
associated among African Americans. In addition to H558R (rs1805124), 3 other common
missense SNPs were identified among African Americans (Table 6). The missense variant
rs7626962 S1102Y (MAF 5.1%) was associated with a 7.4 ms decrease in PR interval
(P=2.8×10−03) among African Americans. This variant was not present in CHARGE sample
of European-ancestry participants. None of the 6 common synonymous variants identified
were associated with PR or QRS intervals.
Discussion
We conducted targeted exonic sequencing of the SCN5A gene to identify rare and common
variants and determine their association with the PR and QRS intervals. We combined
sequencing data from three separate consortia – the CHARGE, NHLBI’s ESP, and UK10K
– and examined associations among those of European and African ancestry. Our approach
facilitated a novel examination of rare and common coding variants of the cardiac SCN5A
sodium channel and their relations with highly accessible ECG measures of cardiac
conduction. We identified novel common and rare coding variant associations with cardiac
conduction. Identification of genetic variants may have important implications for
understanding the genetics and heritability of cardiac arrhythmias.
Our investigation focused on genetic variants in coding regions of SCN5A, the predominant
cardiac sodium channel gene, because of this gene’s prominent role in cardiac depolarization
and conduction.31,32 The SCN5A gene is located on chromosome 3 (3p21), contains 28
exons, and encodes the Nav1.5 pore-forming unit integral to the cardiac voltage-gated
sodium channel.33 Variable SCN5A transcript expression has diverse effects on sodium
channel function.34 Common variation in SCN5A has been associated with modest effects on
cardiac conduction among those of European and African ancestries in a number of GWAS
studies conducted by our group and others.10,12,13 Rare or private mutations in SCN5A have
been implicated in an array of conduction defects that include Long QT syndrome type 3,35
Brugada syndrome,36 atrial standstill,37 and sinus node dysfunction.38,39 In particular,
mutations in SCN5A have been associated with pronounced conduction disease due to high-
grade atrioventricular heart block.40–42 While previous studies have shown that common
variants are associated with modest effects and rare or private mutations are associated with
large effects in families with Mendelian disorders, this is the first study to show that the
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combined effect of rare variants in aggregate is associated with cardiac conduction in the
general population.
Of the four common coding variants found among European ancestry individuals, we
identified two novel synonymous associations (rs1805126 and rs6599230) with cardiac
atrioventricular and ventricular conduction, and validated the association of a previously
identified and well-characterized missense variant (rs1805124, H558R). None of the
common variant associations identified among those of European ancestry were found
among African Americans; however, the sample size among African Americans was
considerably smaller than among those of European ancestry, hence limiting power in this
population. Sequencing among African Americans did identify 4 common nonsynonymous
and 6 common synonymous variants; one previously described missense variant (rs7626962,
S1102Y) was associated with PR interval.
Two missense variants were associated with PR interval duration in our study. The common
nonsynonymous SNP rs1805124 (H558R)43 alters molecular electrophysiology in the
presence of additional genetic mutations.44,45 This SNP has been associated with PR and
QRS in GWAS studies. The second missense SNP, a common variant of the SCN5A sodium
channel gene (rs7626962, S1102Y), present among African Americans but largely absent
among those of European ancestry, has been associated with cardiac conduction and
arrhythmias.10,46 Electrophysiologic studies have reported that the S1102Y variant of the
cardiac sodium channel undergoes minimal kinetic shifts at baseline, but when exposed to
other factors, such as cellular acidosis, late INa current is increased.
The two synonymous SNPs described in this manuscript have not been previously
associated with cardiac conduction. The mechanism by which either of these two SNPs may
influence cardiac conduction is unknown and requires further investigation. The effects of
the identified variants on cellular electrophysiology and their interactions with other
mutations require investigation.
In meta-analysis conducted of GWAS data with 1000 genomes imputation from ARIC,
CHS, and FHS, all three common coding variants were associated with an approximate 2 ms
alteration of PR duration and <1 ms of the QRS interval. While the immediate clinical
implications of these modest alterations are limited, the longer term contributions include
enhancing genomic studies, identifying the missing heritability of genetic traits, and
contributing to improved risk stratification. The PR and QRS intervals are easily acquired
from the ECG and have a vast history of use in clinical care and research. Our research
elucidates that multiple genomic variants may influence the durations of these measures of
conduction. Next steps will include exploring genomic associations of rare and common
variants with diseases such as atrial fibrillation, heart block, and cardiomyopathy.
Several limitations deserve consideration. First, genomic sequencing and analysis in
CHARGE, ESP, and UK10K were all performed at distinct sites. While differences in site
sequencing technique, depth of coverage, variant calling methodologies, and quality control
metrics may have contributed towards differential calling of sequenced variants, we
anticipate such misclassifications to bias our findings towards the null. Furthermore,
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sequenced variants were analyzed within each study by SKAT and then meta-analyzed
across the three studies. This meta-analysis approach to SKAT ensures that comparisons are
made only within a single study, thereby ensuring that all study participants have the same
sequencing approach and QC standards, and hence, would not increase the Type I error rate.
Second, the PR and QRS measures may have been altered by unrecognized clinical
conditions or technical differences. We would expect, however, that such biases would again
be non-differential. Finally, although our study is the largest to examine sequence data for
association with cardiac conduction, the meta-analytic sample size of 5581 European and
972 African ancestry individuals is too small to identify variants with modest associations.
In summary, by sequencing the coding region of an important gene in cardiac conduction,
SCN5A, we have identified novel common coding variant associations with atrioventricular
conduction in the general population. Importantly, this is the first study to show that the
combined effect of rare variants in aggregate is associated with cardiac conduction in the
general population. Our work provides insights into the genomic associations of cardiac
conduction in individuals of European and African ancestry.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Distribution of SCN5A variants by function, stratified by common or rare (<1%) minor
allele frequency.
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Panel A is a schematic of Nav1.5, encoded by SCN5A, marking the position of nonsense
and splice-site variants in relation to the pore forming-transmembrane segment domains.
Panel B shows the effect estimates (ms) associated with each rare variant on the y-axis and
the amino acid position is on the x-axis. Numerals I-IV refer to the pore forming domains
and IQ indicates the isoleucine and glutamine positions in the SCN5A sodium channel gene.
Rare coding variants classified as synonymous (green), missense (blue), splice-site (orange)
or nonsense (red).
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